References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2015 Available from http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015.pdfAccessed May 24, 2016
- PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
- KesslerRStahlEVogelmeierCPatient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyChest2006130113314216840393
- RocheNChavannesNHMiravitllesMCOPD symptoms in the morning: impact, evaluation and managementRespir Res20131411224143997
- DahlRGallagherNGreenYQVA149 provides a rapid onset of action which is sustained throughout treatment in patients with COPDEuropean Respiratory Journal201342Suppl 57
- BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
- Jahnz-RozykKSzepielPEarly impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational studyInt J Chron Obstruct Pulmon Dis20151061362325834420
- D’UrzoAFergusonGTvan NoordJAEfficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trialRespir Res20111215622151296
- KerwinEHebertJGallagherNEfficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 studyEur Respir J20124051106111423060624
- BeehKMSinghDDi ScalaLDrollmannAOnce-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trialInt J Chron Obstruct Pulmon Dis2012750351322973092
- ChapmanKRBeehKMBeierJA blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 studyBMC Pulm Med201414424438744
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- KulichKKeiningerDLTipladyBBanerjiDSymptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE studyInt J Chron Obstruct Pulmon Dis201510799425609942
- BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
- KenwardMGRogerJHThe use of baseline covariates in crossover studiesBiostatistics201011111719915170